Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles

Journal of Pathology - Tập 239 Số 1 - Trang 72-83 - 2016
Zheming Lu1, Jindong Sheng2, Yujie Zhang2, Jianhua Deng2, Yong Li3, Aiping Lü4, Juan Zhang5, Huan Yu5, Min Zhang5, Zikai Xiong6, Hai Yan7, Bill H. Diplas7, Youyong Lu8, Baoguo Liu2
1Laboratory of Genetics, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, China
2Department of Head and Neck Surgery, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, China
3Laboratory of Animal Center of the Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, China
4Department of Pathology, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, China
5Novogene Bioinformatics Technology Co, Ltd, 38 Xueqing Road, Beijing, China
6Genetron Health, Inc, 8 Life Science Parkway, Beijing, China
7Department of Pathology, Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center, Durham, NC USA
8Laboratory of Molecular Oncology, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

McLeod, 2013, Controversies in primary treatment of low-risk papillary thyroid cancer, Lancet, 381, 1046, 10.1016/S0140-6736(12)62205-3

Davies, 2006, Increasing incidence of thyroid cancer in the United States, 1973-2002, J Am Med Assoc, 295, 2164, 10.1001/jama.295.18.2164

Iida, 1969, Study of intraglandular dissemination of thyroid cancer, Cancer, 24, 764, 10.1002/1097-0142(196910)24:4<764::AID-CNCR2820240416>3.0.CO;2-S

Katoh, 1992, Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients, Cancer, 70, 1585, 10.1002/1097-0142(19920915)70:6<1585::AID-CNCR2820700623>3.0.CO;2-Z

Baudin, 1998, Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience, Cancer, 83, 553, 10.1002/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO;2-U

Pellegriti, 2004, Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases, J Clin Endocrinol Metab, 89, 3713, 10.1210/jc.2003-031982

Lin, 2009, High recurrent rate of multicentric papillary thyroid carcinoma, Ann Surg Oncol, 16, 2609, 10.1245/s10434-009-0565-7

Ross, 2009, Recurrence after treatment of micropapillary thyroid cancer, Thyroid, 19, 1043, 10.1089/thy.2008.0407

Lombardi, 2010, Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area, World J Surg, 34, 1214, 10.1007/s00268-009-0375-x

So, 2010, Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections, Surgery, 148, 526, 10.1016/j.surg.2010.01.003

Neuhold, 2011, Incidental papillary microcarcinoma of the thyroid - further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up, Ann Surg Oncol, 18, 3430, 10.1245/s10434-011-1663-x

Barczynski, 2013, Prophylactic central neck dissection for papillary thyroid cancer, Br J Surg, 100, 410, 10.1002/bjs.8985

Kim, 2013, Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma, World J Surg, 37, 376, 10.1007/s00268-012-1835-2

Zhao, 2013, Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma, Ann Surg Oncol, 20, 746, 10.1245/s10434-012-2654-2

Iacobone, 2014, Multifocal papillary thyroid carcinoma - a consensus report of the European Society of Endocrine Surgeons (ESES), Langenbecks Arch Surg, 399, 141, 10.1007/s00423-013-1145-7

Jovanovic, 2008, Most multifocal papillary thyroid carcinomas acquire genetic and morphotype diversity through subclonal evolution following the intra-glandular spread of the initial neoplastic clone, J Pathol, 215, 145, 10.1002/path.2342

Kuhn, 2012, Different clonal origin of bilateral papillary thyroid carcinoma, with a review of the literature, Endocr Pathol, 23, 101, 10.1007/s12022-012-9202-2

Lin, 2008, Molecular analysis of multifocal papillary thyroid carcinoma, J Mol Endocrinol, 41, 195, 10.1677/JME-08-0063

McCarthy, 2006, Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas, Clin Cancer Res, 12, 2414, 10.1158/1078-0432.CCR-05-2818

Moniz, 2002, Clonal origin of non-medullary thyroid tumours assessed by non-random X-chromosome inactivation, Eur J Endocrinol, 146, 27, 10.1530/eje.0.1460027

Wang, 2010, Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas, Hum Pathol, 41, 1299, 10.1016/j.humpath.2010.02.008

Giannini, 2007, The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma, J Clin Endocrinol Metab, 92, 3511, 10.1210/jc.2007-0594

Park, 2006, Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci, Cancer, 107, 1831, 10.1002/cncr.22218

Shattuck, 2005, Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma, N Engl J Med, 352, 2406, 10.1056/NEJMoa044190

Sugg, 1998, Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia, J Clin Endocrinol Metab, 83, 4116

2004, Pathology and Genetics of Tumours of Endocrine Organs: World Health Organization Classification of Tumors, 57

Li, 2009, Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics, 25, 1754, 10.1093/bioinformatics/btp324

Koboldt, 2012, VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing, Genome Res, 22, 568, 10.1101/gr.129684.111

Wang, 2010, ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data, Nucleic Acids Res, 38, 10.1093/nar/gkq603

The Cancer Genome Atlas Research Network, 2014, Integrated genomic characterization of papillary thyroid carcinoma, Cell, 159, 676, 10.1016/j.cell.2014.09.050

Liu, 2014, TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer, J Clin Endocrinol Metab, 99, E1130, 10.1210/jc.2013-4048

Xing, 2005, BRAF mutation in thyroid cancer, Endocr Relat Cancer, 12, 245, 10.1677/erc.1.0978

Jang, 2000, Methylation patterns in human androgen receptor gene and clonality analysis, Cancer Res, 60, 864

Mehine, 2013, Characterization of uterine leiomyomas by whole-genome sequencing, N Engl J Med, 369, 43, 10.1056/NEJMoa1302736

Lindberg, 2013, Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins, Eur Urol, 63, 347, 10.1016/j.eururo.2012.03.050

Miao, 2014, Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis, J Hepatol, 61, 840, 10.1016/j.jhep.2014.05.025

Unger, 2004, Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas, J Clin Endocrinol Metab, 89, 4272, 10.1210/jc.2003-031870

Nikiforov, 2011, Molecular genetics and diagnosis of thyroid cancer, Nature Rev Endocrinol, 7, 569, 10.1038/nrendo.2011.142

Slaughter, 1953, Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin, Cancer, 6, 963, 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q

Gazdar, 2009, Multifocal lung cancers - clonality vs field cancerization and does it matter?, J Natl Cancer Inst, 101, 541, 10.1093/jnci/djp059

Howell, 2013, RAS mutations in thyroid cancer, Oncologist, 18, 926, 10.1634/theoncologist.2013-0072

Noguchi, 1994, Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis, Cancer, 74, 872, 10.1002/1097-0142(19940801)74:3<872::AID-CNCR2820740313>3.0.CO;2-P

Pandis, 1995, Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumors, Cancer, 76, 250, 10.1002/1097-0142(19950715)76:2<250::AID-CNCR2820760215>3.0.CO;2-W

Simon, 2001, Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells, Cancer Res, 61, 355

Sidransky, 1992, Clonal origin bladder cancer, N Engl J Med, 326, 737, 10.1056/NEJM199203123261104

Boutros, 2015, Spatial genomic heterogeneity within localized, multifocal prostate cancer, Nature Genet, 47, 736, 10.1038/ng.3315

Bast, 2009, The biology of ovarian cancer: new opportunities for translation, Nature Rev Cancer, 9, 415, 10.1038/nrc2644

Wang, 2009, Evidence for common clonal origin of multifocal lung cancers, J Natl Cancer Inst, 101, 560, 10.1093/jnci/djp054

Fujiki, 2002, p53 gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma, Int J Oncol, 20, 669

Tabor, 2001, Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications, Clin Cancer Res, 7, 1523